nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0673	0.078	CbGbCtD
Oxaliplatin—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0532	0.0616	CbGbCtD
Oxaliplatin—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0516	0.0598	CbGbCtD
Oxaliplatin—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0515	0.0597	CbGbCtD
Oxaliplatin—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.05	0.0579	CbGbCtD
Oxaliplatin—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0467	0.0541	CbGbCtD
Oxaliplatin—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0439	0.0508	CbGbCtD
Oxaliplatin—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0439	0.0508	CbGbCtD
Oxaliplatin—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0438	0.0508	CbGbCtD
Oxaliplatin—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0398	0.0462	CbGbCtD
Oxaliplatin—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0397	0.046	CbGbCtD
Oxaliplatin—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0397	0.046	CbGbCtD
Oxaliplatin—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.038	0.0441	CbGbCtD
Oxaliplatin—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0346	0.0401	CbGbCtD
Oxaliplatin—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0325	0.0377	CbGbCtD
Oxaliplatin—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0294	0.0341	CbGbCtD
Oxaliplatin—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0283	0.0328	CbGbCtD
Oxaliplatin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0254	0.0294	CbGbCtD
Oxaliplatin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0239	0.0276	CbGbCtD
Oxaliplatin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0239	0.0276	CbGbCtD
Oxaliplatin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0216	0.025	CbGbCtD
Oxaliplatin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0181	0.021	CbGbCtD
Oxaliplatin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0164	0.0189	CbGbCtD
Oxaliplatin—MPO—saliva—acquired immunodeficiency syndrome	0.00409	0.0326	CbGeAlD
Oxaliplatin—ATP7A—endothelium—acquired immunodeficiency syndrome	0.00374	0.0298	CbGeAlD
Oxaliplatin—GSTM1—blood plasma—acquired immunodeficiency syndrome	0.00276	0.022	CbGeAlD
Oxaliplatin—MPO—endothelium—acquired immunodeficiency syndrome	0.00201	0.016	CbGeAlD
Oxaliplatin—MT2A—skin of body—acquired immunodeficiency syndrome	0.00184	0.0147	CbGeAlD
Oxaliplatin—MPO—blood plasma—acquired immunodeficiency syndrome	0.00178	0.0142	CbGeAlD
Oxaliplatin—MT1A—digestive system—acquired immunodeficiency syndrome	0.00177	0.0141	CbGeAlD
Oxaliplatin—CA4—nerve—acquired immunodeficiency syndrome	0.00175	0.0139	CbGeAlD
Oxaliplatin—GSTP1—blood plasma—acquired immunodeficiency syndrome	0.00173	0.0138	CbGeAlD
Oxaliplatin—ATP7B—blood—acquired immunodeficiency syndrome	0.00151	0.012	CbGeAlD
Oxaliplatin—MT2A—lymphoid tissue—acquired immunodeficiency syndrome	0.00149	0.0119	CbGeAlD
Oxaliplatin—MT1A—lung—acquired immunodeficiency syndrome	0.00148	0.0118	CbGeAlD
Oxaliplatin—MT2A—digestive system—acquired immunodeficiency syndrome	0.00147	0.0117	CbGeAlD
Oxaliplatin—GSTT1—lymphoid tissue—acquired immunodeficiency syndrome	0.00146	0.0116	CbGeAlD
Oxaliplatin—GSTT1—digestive system—acquired immunodeficiency syndrome	0.00144	0.0115	CbGeAlD
Oxaliplatin—ATP7B—vagina—acquired immunodeficiency syndrome	0.0014	0.0112	CbGeAlD
Oxaliplatin—GSTT1—blood—acquired immunodeficiency syndrome	0.00138	0.0109	CbGeAlD
Oxaliplatin—MT2A—spinal cord—acquired immunodeficiency syndrome	0.00135	0.0108	CbGeAlD
Oxaliplatin—GSTM1—skin of body—acquired immunodeficiency syndrome	0.00133	0.0106	CbGeAlD
Oxaliplatin—ATP7B—lung—acquired immunodeficiency syndrome	0.00132	0.0105	CbGeAlD
Oxaliplatin—MT2A—lung—acquired immunodeficiency syndrome	0.00123	0.0098	CbGeAlD
Oxaliplatin—ATP7B—nervous system—acquired immunodeficiency syndrome	0.00123	0.00977	CbGeAlD
Oxaliplatin—ATP7A—blood—acquired immunodeficiency syndrome	0.00122	0.00968	CbGeAlD
Oxaliplatin—GSTT1—lung—acquired immunodeficiency syndrome	0.00121	0.00959	CbGeAlD
Oxaliplatin—ATP7B—central nervous system—acquired immunodeficiency syndrome	0.00118	0.0094	CbGeAlD
Oxaliplatin—ATP7A—bone marrow—acquired immunodeficiency syndrome	0.00118	0.00937	CbGeAlD
Oxaliplatin—ATP7A—spinal cord—acquired immunodeficiency syndrome	0.00117	0.00933	CbGeAlD
Oxaliplatin—MT2A—nervous system—acquired immunodeficiency syndrome	0.00114	0.00908	CbGeAlD
Oxaliplatin—ATP7A—vagina—acquired immunodeficiency syndrome	0.00113	0.00898	CbGeAlD
Oxaliplatin—GSTT1—nervous system—acquired immunodeficiency syndrome	0.00112	0.00888	CbGeAlD
Oxaliplatin—MT2A—central nervous system—acquired immunodeficiency syndrome	0.0011	0.00874	CbGeAlD
Oxaliplatin—SLC31A1—digestive system—acquired immunodeficiency syndrome	0.00109	0.00867	CbGeAlD
Oxaliplatin—GSTM1—lymphoid tissue—acquired immunodeficiency syndrome	0.00108	0.00857	CbGeAlD
Oxaliplatin—ATP7A—lung—acquired immunodeficiency syndrome	0.00107	0.00849	CbGeAlD
Oxaliplatin—SOD1—blood—acquired immunodeficiency syndrome	0.00106	0.00848	CbGeAlD
Oxaliplatin—GSTM1—digestive system—acquired immunodeficiency syndrome	0.00106	0.00846	CbGeAlD
Oxaliplatin—NQO1—retina—acquired immunodeficiency syndrome	0.00106	0.00845	CbGeAlD
Oxaliplatin—MT1A—brain—acquired immunodeficiency syndrome	0.00105	0.00833	CbGeAlD
Oxaliplatin—SLC31A1—blood—acquired immunodeficiency syndrome	0.00104	0.00826	CbGeAlD
Oxaliplatin—SOD1—bone marrow—acquired immunodeficiency syndrome	0.00103	0.0082	CbGeAlD
Oxaliplatin—SOD1—spinal cord—acquired immunodeficiency syndrome	0.00103	0.00817	CbGeAlD
Oxaliplatin—GSTM1—blood—acquired immunodeficiency syndrome	0.00101	0.00806	CbGeAlD
Oxaliplatin—MT1A—lymph node—acquired immunodeficiency syndrome	0.00101	0.00805	CbGeAlD
Oxaliplatin—SLC31A1—bone marrow—acquired immunodeficiency syndrome	0.001	0.00799	CbGeAlD
Oxaliplatin—SLC31A1—spinal cord—acquired immunodeficiency syndrome	0.001	0.00796	CbGeAlD
Oxaliplatin—SOD1—vagina—acquired immunodeficiency syndrome	0.000987	0.00786	CbGeAlD
Oxaliplatin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000975	0.00776	CbGeAlD
Oxaliplatin—SLC31A1—vagina—acquired immunodeficiency syndrome	0.000962	0.00766	CbGeAlD
Oxaliplatin—GSTP1—retina—acquired immunodeficiency syndrome	0.000948	0.00755	CbGeAlD
Oxaliplatin—ATP7B—brain—acquired immunodeficiency syndrome	0.000938	0.00746	CbGeAlD
Oxaliplatin—SOD1—lung—acquired immunodeficiency syndrome	0.000933	0.00743	CbGeAlD
Oxaliplatin—NQO1—skin of body—acquired immunodeficiency syndrome	0.000932	0.00741	CbGeAlD
Oxaliplatin—SLC31A1—lung—acquired immunodeficiency syndrome	0.00091	0.00724	CbGeAlD
Oxaliplatin—ATP7B—lymph node—acquired immunodeficiency syndrome	0.000906	0.00721	CbGeAlD
Oxaliplatin—GSTM1—lung—acquired immunodeficiency syndrome	0.000888	0.00707	CbGeAlD
Oxaliplatin—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000877	0.00698	CbGeAlD
Oxaliplatin—MT2A—brain—acquired immunodeficiency syndrome	0.000872	0.00694	CbGeAlD
Oxaliplatin—MPO—skin of body—acquired immunodeficiency syndrome	0.000856	0.00682	CbGeAlD
Oxaliplatin—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000843	0.00671	CbGeAlD
Oxaliplatin—SLC31A1—nervous system—acquired immunodeficiency syndrome	0.000842	0.0067	CbGeAlD
Oxaliplatin—GSTP1—skin of body—acquired immunodeficiency syndrome	0.000833	0.00663	CbGeAlD
Oxaliplatin—GSTM1—nervous system—acquired immunodeficiency syndrome	0.000822	0.00654	CbGeAlD
Oxaliplatin—SLC31A1—central nervous system—acquired immunodeficiency syndrome	0.000811	0.00646	CbGeAlD
Oxaliplatin—GSTM1—central nervous system—acquired immunodeficiency syndrome	0.000792	0.0063	CbGeAlD
Oxaliplatin—ATP7A—brain—acquired immunodeficiency syndrome	0.000755	0.00601	CbGeAlD
Oxaliplatin—NQO1—digestive system—acquired immunodeficiency syndrome	0.000745	0.00593	CbGeAlD
Oxaliplatin—ATP7A—lymph node—acquired immunodeficiency syndrome	0.000729	0.00581	CbGeAlD
Oxaliplatin—MPO—lymphoid tissue—acquired immunodeficiency syndrome	0.000694	0.00552	CbGeAlD
Oxaliplatin—MPO—digestive system—acquired immunodeficiency syndrome	0.000685	0.00545	CbGeAlD
Oxaliplatin—NQO1—spinal cord—acquired immunodeficiency syndrome	0.000684	0.00544	CbGeAlD
Oxaliplatin—GSTP1—lymphoid tissue—acquired immunodeficiency syndrome	0.000674	0.00537	CbGeAlD
Oxaliplatin—GSTP1—digestive system—acquired immunodeficiency syndrome	0.000666	0.0053	CbGeAlD
Oxaliplatin—SOD1—brain—acquired immunodeficiency syndrome	0.000661	0.00526	CbGeAlD
Oxaliplatin—NQO1—vagina—acquired immunodeficiency syndrome	0.000658	0.00524	CbGeAlD
Oxaliplatin—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000654	0.00521	CbGeAlD
Oxaliplatin—MPO—blood—acquired immunodeficiency syndrome	0.000653	0.00519	CbGeAlD
Oxaliplatin—SLC31A1—brain—acquired immunodeficiency syndrome	0.000644	0.00512	CbGeAlD
Oxaliplatin—SOD1—lymph node—acquired immunodeficiency syndrome	0.000638	0.00508	CbGeAlD
Oxaliplatin—GSTP1—blood—acquired immunodeficiency syndrome	0.000634	0.00505	CbGeAlD
Oxaliplatin—MPO—bone marrow—acquired immunodeficiency syndrome	0.000632	0.00503	CbGeAlD
Oxaliplatin—MPO—spinal cord—acquired immunodeficiency syndrome	0.000629	0.005	CbGeAlD
Oxaliplatin—GSTM1—brain—acquired immunodeficiency syndrome	0.000628	0.005	CbGeAlD
Oxaliplatin—NQO1—lung—acquired immunodeficiency syndrome	0.000622	0.00495	CbGeAlD
Oxaliplatin—SLC31A1—lymph node—acquired immunodeficiency syndrome	0.000622	0.00495	CbGeAlD
Oxaliplatin—GSTP1—bone marrow—acquired immunodeficiency syndrome	0.000614	0.00489	CbGeAlD
Oxaliplatin—GSTP1—spinal cord—acquired immunodeficiency syndrome	0.000611	0.00486	CbGeAlD
Oxaliplatin—GSTM1—lymph node—acquired immunodeficiency syndrome	0.000607	0.00483	CbGeAlD
Oxaliplatin—GSTP1—vagina—acquired immunodeficiency syndrome	0.000588	0.00468	CbGeAlD
Oxaliplatin—NQO1—nervous system—acquired immunodeficiency syndrome	0.000576	0.00459	CbGeAlD
Oxaliplatin—MPO—lung—acquired immunodeficiency syndrome	0.000572	0.00455	CbGeAlD
Oxaliplatin—SLC22A1—blood—acquired immunodeficiency syndrome	0.000568	0.00452	CbGeAlD
Oxaliplatin—GSTP1—lung—acquired immunodeficiency syndrome	0.000556	0.00443	CbGeAlD
Oxaliplatin—NQO1—central nervous system—acquired immunodeficiency syndrome	0.000555	0.00442	CbGeAlD
Oxaliplatin—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000534	0.00425	CbGeAlD
Oxaliplatin—MPO—nervous system—acquired immunodeficiency syndrome	0.00053	0.00422	CbGeAlD
Oxaliplatin—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.00053	0.00422	CbGeAlD
Oxaliplatin—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000526	0.00419	CbGeAlD
Oxaliplatin—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000523	0.00417	CbGeAlD
Oxaliplatin—GSTP1—nervous system—acquired immunodeficiency syndrome	0.000515	0.0041	CbGeAlD
Oxaliplatin—MPO—central nervous system—acquired immunodeficiency syndrome	0.00051	0.00406	CbGeAlD
Oxaliplatin—ABCC2—blood—acquired immunodeficiency syndrome	0.000509	0.00405	CbGeAlD
Oxaliplatin—CA4—digestive system—acquired immunodeficiency syndrome	0.000507	0.00404	CbGeAlD
Oxaliplatin—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000503	0.004	CbGeAlD
Oxaliplatin—CYP1B1—blood—acquired immunodeficiency syndrome	0.000499	0.00397	CbGeAlD
Oxaliplatin—GSTP1—central nervous system—acquired immunodeficiency syndrome	0.000496	0.00395	CbGeAlD
Oxaliplatin—CA4—blood—acquired immunodeficiency syndrome	0.000483	0.00385	CbGeAlD
Oxaliplatin—SLC22A3—lung—acquired immunodeficiency syndrome	0.000476	0.00378	CbGeAlD
Oxaliplatin—CA4—bone marrow—acquired immunodeficiency syndrome	0.000468	0.00372	CbGeAlD
Oxaliplatin—CA4—spinal cord—acquired immunodeficiency syndrome	0.000466	0.00371	CbGeAlD
Oxaliplatin—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000463	0.00368	CbGeAlD
Oxaliplatin—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000461	0.00367	CbGeAlD
Oxaliplatin—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000444	0.00353	CbGeAlD
Oxaliplatin—NQO1—brain—acquired immunodeficiency syndrome	0.000441	0.00351	CbGeAlD
Oxaliplatin—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.00044	0.0035	CbGeAlD
Oxaliplatin—CYP1B1—lung—acquired immunodeficiency syndrome	0.000437	0.00348	CbGeAlD
Oxaliplatin—NQO1—lymph node—acquired immunodeficiency syndrome	0.000426	0.00339	CbGeAlD
Oxaliplatin—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000424	0.00337	CbGeAlD
Oxaliplatin—CA4—lung—acquired immunodeficiency syndrome	0.000424	0.00337	CbGeAlD
Oxaliplatin—MPO—brain—acquired immunodeficiency syndrome	0.000405	0.00322	CbGeAlD
Oxaliplatin—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000405	0.00322	CbGeAlD
Oxaliplatin—GSTP1—brain—acquired immunodeficiency syndrome	0.000394	0.00313	CbGeAlD
Oxaliplatin—CA4—nervous system—acquired immunodeficiency syndrome	0.000392	0.00312	CbGeAlD
Oxaliplatin—MPO—lymph node—acquired immunodeficiency syndrome	0.000391	0.00311	CbGeAlD
Oxaliplatin—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.00039	0.0031	CbGeAlD
Oxaliplatin—GSTP1—lymph node—acquired immunodeficiency syndrome	0.00038	0.00303	CbGeAlD
Oxaliplatin—CA4—central nervous system—acquired immunodeficiency syndrome	0.000378	0.00301	CbGeAlD
Oxaliplatin—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000375	0.00298	CbGeAlD
Oxaliplatin—ABCG2—blood—acquired immunodeficiency syndrome	0.000371	0.00295	CbGeAlD
Oxaliplatin—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.00037	0.00294	CbGeAlD
Oxaliplatin—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000359	0.00286	CbGeAlD
Oxaliplatin—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000358	0.00285	CbGeAlD
Oxaliplatin—CYP1A2—blood—acquired immunodeficiency syndrome	0.000357	0.00284	CbGeAlD
Oxaliplatin—CYP1A1—blood—acquired immunodeficiency syndrome	0.000352	0.00281	CbGeAlD
Oxaliplatin—SLC22A1—brain—acquired immunodeficiency syndrome	0.000352	0.0028	CbGeAlD
Oxaliplatin—ABCG2—vagina—acquired immunodeficiency syndrome	0.000344	0.00274	CbGeAlD
Oxaliplatin—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000342	0.00272	CbGeAlD
Oxaliplatin—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000337	0.00269	CbGeAlD
Oxaliplatin—SLC22A3—brain—acquired immunodeficiency syndrome	0.000337	0.00268	CbGeAlD
Oxaliplatin—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000327	0.0026	CbGeAlD
Oxaliplatin—ABCG2—lung—acquired immunodeficiency syndrome	0.000325	0.00259	CbGeAlD
Oxaliplatin—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000325	0.00259	CbGeAlD
Oxaliplatin—MT2A—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	0.000323	0.0283	CbGpPWpGaD
Oxaliplatin—CYP2E1—blood—acquired immunodeficiency syndrome	0.000321	0.00256	CbGeAlD
Oxaliplatin—MT2A—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	0.00032	0.028	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.000315	0.0275	CbGpPWpGaD
Oxaliplatin—CYP1A2—lung—acquired immunodeficiency syndrome	0.000313	0.00249	CbGeAlD
Oxaliplatin—MT2A—Interferon gamma signaling—HLA-B—acquired immunodeficiency syndrome	0.000311	0.0272	CbGpPWpGaD
Oxaliplatin—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.00031	0.00246	CbGeAlD
Oxaliplatin—CYP1B1—brain—acquired immunodeficiency syndrome	0.000309	0.00246	CbGeAlD
Oxaliplatin—CYP1A1—lung—acquired immunodeficiency syndrome	0.000309	0.00246	CbGeAlD
Oxaliplatin—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000305	0.00243	CbGeAlD
Oxaliplatin—CA4—brain—acquired immunodeficiency syndrome	0.0003	0.00239	CbGeAlD
Oxaliplatin—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000299	0.00238	CbGeAlD
Oxaliplatin—NQO1—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.000295	0.0258	CbGpPWpGaD
Oxaliplatin—CA4—lymph node—acquired immunodeficiency syndrome	0.00029	0.00231	CbGeAlD
Oxaliplatin—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000286	0.00228	CbGeAlD
Oxaliplatin—CYP2E1—lung—acquired immunodeficiency syndrome	0.000282	0.00224	CbGeAlD
Oxaliplatin—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000275	0.00219	CbGeAlD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000268	0.0234	CbGpPWpGaD
Oxaliplatin—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000261	0.00208	CbGeAlD
Oxaliplatin—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000251	0.002	CbGeAlD
Oxaliplatin—MPO—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000234	0.0204	CbGpPWpGaD
Oxaliplatin—ABCG2—brain—acquired immunodeficiency syndrome	0.00023	0.00183	CbGeAlD
Oxaliplatin—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000223	0.00177	CbGeAlD
Oxaliplatin—CYP1A1—brain—acquired immunodeficiency syndrome	0.000219	0.00174	CbGeAlD
Oxaliplatin—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000211	0.00168	CbGeAlD
Oxaliplatin—SOD1—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000211	0.0185	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—IFNA1—acquired immunodeficiency syndrome	0.000202	0.0176	CbGpPWpGaD
Oxaliplatin—CYP2E1—brain—acquired immunodeficiency syndrome	0.000199	0.00159	CbGeAlD
Oxaliplatin—MT2A—Interferon gamma signaling—IFNG—acquired immunodeficiency syndrome	0.000192	0.0168	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.00019	0.0166	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000184	0.0161	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000177	0.0155	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000172	0.015	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000171	0.0149	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.000169	0.0148	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000157	0.0137	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000157	0.0137	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—HLA-B—acquired immunodeficiency syndrome	0.000152	0.0133	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.00015	0.0131	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000145	0.0127	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00014	0.0122	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000137	0.012	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000135	0.0118	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000129	0.0113	CbGpPWpGaD
Oxaliplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TNF—acquired immunodeficiency syndrome	0.000128	0.0112	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000128	0.0112	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000122	0.0107	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet degranulation—ALB—acquired immunodeficiency syndrome	0.00012	0.0105	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.000115	0.01	CbGpPWpGaD
Oxaliplatin—SOD1—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	0.000114	0.00999	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000113	0.00991	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000111	0.00973	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000111	0.00971	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000106	0.0093	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000106	0.0093	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.000105	0.00922	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000104	0.00912	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000102	0.00888	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000102	0.00887	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.000101	0.00887	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000101	0.00886	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	9.93e-05	0.00868	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—IL2—acquired immunodeficiency syndrome	9.89e-05	0.00865	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	9.69e-05	0.00847	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—IFNG—acquired immunodeficiency syndrome	9.39e-05	0.00821	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	9.38e-05	0.0082	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	9.38e-05	0.0082	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	9.24e-05	0.00808	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	8.87e-05	0.00775	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	8.86e-05	0.00774	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	8.85e-05	0.00773	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—AGPS—acquired immunodeficiency syndrome	8.63e-05	0.00755	CbGpPWpGaD
Oxaliplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—acquired immunodeficiency syndrome	8.37e-05	0.00732	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TNF—acquired immunodeficiency syndrome	8.26e-05	0.00722	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	8.19e-05	0.00716	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	8.16e-05	0.00713	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—ACTG1—acquired immunodeficiency syndrome	7.59e-05	0.00663	CbGpPWpGaD
Oxaliplatin—SLC31A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	7.44e-05	0.0065	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TNF—acquired immunodeficiency syndrome	7.21e-05	0.0063	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	7.15e-05	0.00625	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	6.96e-05	0.00608	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—IL6—acquired immunodeficiency syndrome	6.67e-05	0.00583	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	6.56e-05	0.00574	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—TAT—acquired immunodeficiency syndrome	6.54e-05	0.00572	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	6.27e-05	0.00548	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—MBL2—acquired immunodeficiency syndrome	6.24e-05	0.00545	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	6.18e-05	0.00541	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—IL6—acquired immunodeficiency syndrome	5.82e-05	0.00508	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—TAT—acquired immunodeficiency syndrome	5.8e-05	0.00507	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	5.73e-05	0.00501	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	5.57e-05	0.00487	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.56e-05	0.00486	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—TAT—acquired immunodeficiency syndrome	5.56e-05	0.00486	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—TAT—acquired immunodeficiency syndrome	5.42e-05	0.00474	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—IFNA1—acquired immunodeficiency syndrome	5.38e-05	0.0047	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	5.32e-05	0.00465	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	5.3e-05	0.00463	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.97e-05	0.00435	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—AGPS—acquired immunodeficiency syndrome	4.93e-05	0.00431	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CCR2—acquired immunodeficiency syndrome	4.89e-05	0.00427	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.73e-05	0.00413	CbGpPWpGaD
Oxaliplatin—ATP7B—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.64e-05	0.00405	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	4.62e-05	0.00404	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.61e-05	0.00403	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	4.5e-05	0.00394	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	4.5e-05	0.00394	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IFNA1—acquired immunodeficiency syndrome	4.4e-05	0.00385	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	4.31e-05	0.00377	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	4.29e-05	0.00375	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD79A—acquired immunodeficiency syndrome	4.27e-05	0.00374	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—CSF2—acquired immunodeficiency syndrome	4.21e-05	0.00368	CbGpPWpGaD
Oxaliplatin—ATP7A—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.94e-05	0.00345	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	3.81e-05	0.00333	CbGpPWpGaD
Oxaliplatin—SLC31A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.78e-05	0.0033	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—TAT—acquired immunodeficiency syndrome	3.74e-05	0.00327	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	3.65e-05	0.00319	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD40LG—acquired immunodeficiency syndrome	3.48e-05	0.00305	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD8A—acquired immunodeficiency syndrome	3.44e-05	0.00301	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CSF2—acquired immunodeficiency syndrome	3.44e-05	0.00301	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-B—acquired immunodeficiency syndrome	3.31e-05	0.0029	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	3.28e-05	0.00286	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—AGPS—acquired immunodeficiency syndrome	3.18e-05	0.00278	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.06e-05	0.00268	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	2.77e-05	0.00243	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	2.77e-05	0.00243	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—ALB—acquired immunodeficiency syndrome	2.74e-05	0.0024	CbGpPWpGaD
Oxaliplatin—SLC22A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.74e-05	0.00239	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	2.73e-05	0.00239	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—TAT—acquired immunodeficiency syndrome	2.6e-05	0.00228	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	2.43e-05	0.00212	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	2.37e-05	0.00207	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.34e-05	0.00205	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—IL2—acquired immunodeficiency syndrome	2.22e-05	0.00194	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.21e-05	0.00194	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	2.2e-05	0.00192	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.19e-05	0.00191	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IFNG—acquired immunodeficiency syndrome	2.05e-05	0.00179	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.01e-05	0.00176	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.99e-05	0.00174	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD4—acquired immunodeficiency syndrome	1.98e-05	0.00173	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.95e-05	0.00171	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	1.92e-05	0.00168	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.86e-05	0.00162	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IL2—acquired immunodeficiency syndrome	1.82e-05	0.00159	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—ALB—acquired immunodeficiency syndrome	1.77e-05	0.00155	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	1.77e-05	0.00155	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	1.77e-05	0.00155	CbGpPWpGaD
Oxaliplatin—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.72e-05	0.0015	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	1.7e-05	0.00149	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	1.6e-05	0.0014	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.6e-05	0.0014	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.45e-05	0.00126	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.39e-05	0.00122	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.36e-05	0.00119	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—ALB—acquired immunodeficiency syndrome	1.14e-05	0.000997	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IL6—acquired immunodeficiency syndrome	1.07e-05	0.000935	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.02e-05	0.000894	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.02e-05	0.000891	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.01e-05	0.000887	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—ALB—acquired immunodeficiency syndrome	1.01e-05	0.000884	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—ALB—acquired immunodeficiency syndrome	9.7e-06	0.000848	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—ALB—acquired immunodeficiency syndrome	9.45e-06	0.000826	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.82e-06	0.000771	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.73e-06	0.000763	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	8.69e-06	0.00076	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.14e-06	0.000711	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	6.52e-06	0.00057	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.28e-06	0.000549	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	4.54e-06	0.000397	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	4.13e-06	0.000361	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	4.09e-06	0.000357	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4e-06	0.00035	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	3.81e-06	0.000333	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	2.97e-06	0.000259	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	2.8e-06	0.000244	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.78e-06	0.000156	CbGpPWpGaD
